  | Absil, L., Rigaux, E., Tafforeau, L., Body, J.-J., Nonclercq, D., & Journe, F. (01 April 2021). Involvement of FXR in the OPG/RANKL pathway of breast and prostate cancer cells. Bone Reports, 14, 101036. doi:10.1016/j.bonr.2021.101036  Peer Reviewed verified by ORBi |
| Absil, L., Journe, F., Larsimont, D., Body, J.-J., Tafforeau, L., & Nonclercq, D. (10 July 2020). Farnesoid X receptor as marker of osteotropism of breast cancers through its role in the osteomimetism of tumor cells. BMC Cancer, 20, 640. doi:10.1186/s12885-020-07106-7 Peer Reviewed verified by ORBi |
Absil, L., Journe, F., & Nonclercq, D. (13 September 2018). Role of the farnesoid X receptor in the osteotropism of breast cancer cells. Paper presented at GIGA - cancer days 2018, Liège, Belgium. |
Absil, L., Journe, F., & Nonclercq, D. (08 June 2018). The role of FXR in the osteomimetism in MCF-7 Breast Cancer Cells. Poster session presented at Belgian Society for Cell and Development Biology, Liège, Belgium. |
Absil, L., Journe, F., & Nonclercq, D. (07 March 2018). Implication du FXR dans l'ostéomimétisme des cellules cancéreuses mammaires MCF-7. Paper presented at Journée doctorale transfrontalière, Reims, France. |
Absil, L., Journe, F., & Nonclercq, D. (01 February 2018). The role of FXR in the osteomimetism in MCF-7 Breast Cancer Cells. Poster session presented at télévie Cancer Seminar, Bruxelles (Erasme), Belgium. |
Absil, L., Journe, F., & Nonclercq, D. (07 November 2017). Osteotropism induced by CDCA is interfered by lithocholic acid in breast cancer. Paper presented at European Gynecological Oncology Congress, Vienna, Austria. |
Absil, L., Journe, F., & Nonclercq, D. (18 May 2017). Osteotropism in MCF-7 Breast Cancer Cells. Poster session presented at BIT's 10th Annual World Cancer Congress 2017, Barcelona, Spain. |
Absil, L., Journe, F., Saussez, S., & Nonclercq, D. (07 March 2017). Chenodeoxycholic acid (CDCA) promotes osteomimetism in MDA-MB-231 cells. Poster session presented at Huitième édition montoise du MdC : le Mardi des Chercheurs 2017, UMons, Belgium. |
| Valentini, X., Absil, L., laurent, G., Robbe, A., Laurent, S., Muller, R., Legrand, A., & Nonclercq, D. (30 January 2017). Toxicity of TiO2 nanoparticules on the NRK52E renal cell line. Molecular and Cellular Toxicology, 13, 419-431. doi:10.1007/s13273-017-0046-1 Peer reviewed |
Absil, L., Journe, F., Saussez, S., & Nonclercq, D. (08 December 2016). Bile acids promote osteomimetism in MDA-MB-231 cells. Poster session presented at télévie's Researchers Seminar, UCL Bruxelles, Belgium. |
Valentini, X., Absil, L., laurent, G., Frau, A., Rugira Uwamahoro, P., & Nonclercq, D. (08 September 2016). Study of the oxidative stress caused by the exposure to TiO2 nanoparticles in vitro and in vivo. Poster session presented at RBSM Golden Jubilee Meeting of the Royal Belgium Society for Microscopy, Bruxelles, Belgium. |
Absil, L., Journe, F., laurent, G., Larsimont, D., Saussez, S., Body, J.-J., & Nonclercq, D. (08 September 2016). Bile acids and estrogens promote the cell proliferation and osteomimetism in MCF-7 cells. Poster session presented at RBSM Golden Jubilee Meeting of the Royal Belgium Society for Microscopy, Bruxelles, Belgium. |
Absil, L., Journe, F., laurent, G., Larsimont, D., Saussez, S., Body, J.-J., & Nonclercq, D. (01 July 2016). Farnesoid X receptor expression predicts bone metastases from breast cancer. Poster session presented at Opening Symposium of the ULB- cancer research centre, Brussels, Belgium. |
Absil, L., Journe, F., & Nonclercq, D. (27 May 2016). FXR is involved in the control of cell proliferation in breast cancer cells. Poster session presented at Stem Cells as Disease Model and for Gene Therapy, Brussels, Belgium. |
Absil, L., Journe, F., & Nonclercq, D. (18 May 2016). Implication du FXR dans la prolifération cellulaire des cellules de carcinomes mammaires. Poster session presented at Matinée des chercheurs, Valenciennes, Université de Valenciennes et du Hainaut Cambrésis, France. |
Absil, L., Journe, F., laurent, G., Frau, A., Ghanem, G., & Nonclercq, D. (30 January 2016). Phenotypic variations associated to V600EBRAF mutation among metastatic melanoma cell lines. Poster session presented at BACR Annual Meeting, ULB Erasme, Belgium. |
Journe, F., Wiedig, M., Monrandini, R., El Hajj, P., Krayem, M., Sales, F., Theunis, A., Larsimont, D., Absil, L., Laurent, G., Gilot, D., Galibert, M.-D., Awada, A., & Ghanem, G. (08 March 2013). Tyrosine-related protein 1 (TYRP1) expression correlates with markers of both differentiation/pigmentation and proliferation in melanoma. Poster session presented at Journée des doctorants, Bruxelles, Belgium. |